Tandem Diabetes Care to Present at the Cowen and Company

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Tandem Diabetes Care to Present at the Cowen and Company 35th Annual Health Care Conference

SAN DIEGO, Feb. 27, 2015 (GLOBE NEWSWIRE) -- Tandem Diabetes Care®, Inc. (Nasdaq: TNDM ), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced that Kim Blickenstaff, president and CEO, will present a company update at the Cowen and Company 35 th Annual Health Care Conference in Boston, MA. The presentation will take place on Tuesday, March 3, 2015 at 9:20am Eastern Time (6:20am Pacific Time).

The presentation will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com in the "Investor Events" section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. ( www.tandemdiabetes.com ) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump currently on the market, and the t:flex™ Insulin Pump, the first pump designed for people with greater insulin requirements. Tandem is based in San Diego, California.

Follow Tandem Diabetes Care on:

Twitter @tandemdiabetes, use #tslim, #tconnect and $TNDM.
Facebook at www.facebook.com/TandemDiabetes
LinkedIn at www.linkedin.com/company/TandemDiabetes

t:flex is a trademark, and t:slim and Tandem Diabetes Care are registered trademarks of Tandem Diabetes Care, Inc.

Media Contact: Steve Sabicer 714-907-6264 Investor Contact: Susan Morrison 858-366-6900 x7005

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Discovering Innovation: Smitty's Car Wash on Public Television

Updated Category News Views 332

Innovation at Smitty's Car Wash Viewers are in for an enlightening experience as the show "Empowered with Meg Ryan" spotlights Smitty's Car Wash, a pioneer in the express tunnel car wash industry. This segment promises to challenge traditional notions of car washing, showcasing how modern methods and technology integrate to create not just services, but transformative...

Continue Reading
ASPCA® Expands Veterinary Services with New Clinic Opening

Updated Category News Views 144

ASPCA® Opens New Community Veterinary Clinic in New York The ASPCA Community Veterinary Clinic, supported by The Rachael Ray Foundation, is set to meet the needs of many pets in the local area. This opening in New York City is a crucial advancement in providing vital veterinary care to communities in need. Veterinary Services That Are Within Reach Thousands of pets in...

Continue Reading
Big Boost for European Innovation with Novo Nordisk Foundation's Grant

Updated Category News Views 91

Novo Nordisk Foundation Boosts Innovation Funding In a groundbreaking move to enhance innovation in Europe, the Novo Nordisk Foundation is investing up to DKK 5.5 billion (approximately EUR 736 million) into the BioInnovation Institute (BII). This funding is set to play a transformative role in supporting entrepreneurs and startups within the life sciences sector....

Continue Reading
Legal Challenges for 3D Systems: Investor Action Recommended

Updated Category News Views 165

Overview of the Legal Situation Recent events surrounding 3D Systems Corporation have raised significant concerns among investors. The company is currently facing a class action lawsuit that alleges violations of securities laws. Investors in 3D Systems are encouraged to stay informed about the progress of this legal challenge and consider their options moving forward....

Continue Reading
Inhibikase Therapeutics Updates: Q2 2025 Financial Overview

Updated Category News Views 135

Inhibikase Therapeutics Q2 2025 Financial Update Inhibikase Therapeutics, Inc. (NASDAQ: IKT) is making notable strides as a clinical-stage pharmaceutical company dedicated to developing innovative therapeutics aimed at addressing cardiopulmonary diseases, particularly Pulmonary Arterial Hypertension (PAH). Recently, they announced their financial results for the second...

Continue Reading